Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.56 USD | +1.83% | +22.39% | +32.16% |
07-02 | Inozyme Pharma Says US FDA Granted Fast Track Designation to INZ-701 to Treat ABCC6 Deficiency | MT |
07-02 | Inozyme Pharma Gets FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.16% | 338M | |
+25.39% | 46.56B | |
+45.38% | 41.67B | |
+0.37% | 41.16B | |
+33.38% | 32.4B | |
+21.02% | 28.18B | |
-6.35% | 28.1B | |
+49.10% | 14.52B | |
+47.53% | 13.74B | |
+3.36% | 12.17B |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- Insider Buy: Inozyme Pharma